DAVID EMERSON JORDEN Insider Trading $AURX Nuo Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID EMERSON JORDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID EMERSON JORDEN. DAVID EMERSON JORDEN is Acting CFO in Nuo Therapeutics, Inc. ($NUOT) and CEO and CFO in Nuo Therapeutics, Inc. ($NUOT) and CEO, CFO in Nuo Therapeutics, Inc. ($NUOT) and Director in Nuo Therapeutics, Inc. ($NUOT) and Acting Chief Financial Officer in PLx Pharma Inc. ($DPRX).
DAVID EMERSON JORDEN in Nuo Therapeutics, Inc.
Trading Symbol: AURXIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DAVID EMERSON JORDEN: CEO, CFO, CEO and CFO, Acting CFO, Director
Holdings: 557,146 shares
Current Value: $5,571
Latest Transaction: Jan 03 2019
$AURX Market Capitalization: $1.82M
$AURX Previous Close: $0.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID EMERSON JORDEN in Nuo Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2019 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 125,000 | 50,000 | 125,000 | |
Aug 13 2018 | AURX | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 0.40 | 192,710 | 77,084 | 192,710 | |
Aug 14 2017 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Buy | P | 0.22 | 247,500 | 54,995 | 557,146 | 309.6 K to 557.1 K (+79.93 %) |
Jan 11 2017 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO, CFO | Option Exercise | A | 1.00 | 162,500 | 162,500 | 162,500 | |
Jul 29 2016 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO and CFO | Buy | J | 0.00 | 167 | 0 | 167 | 0 to 167 |
Jul 29 2016 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO and CFO | Buy | J | 0.00 | 55,915 | 0 | 309,646 | 253.7 K to 309.6 K (+22.04 %) |
Jul 29 2016 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO and CFO | Buy | J | 0.00 | 62,182 | 0 | 253,731 | 191.5 K to 253.7 K (+32.46 %) |
Jul 29 2016 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO and CFO | Buy | J | 0.00 | 54,049 | 0 | 191,549 | 137.5 K to 191.5 K (+39.31 %) |
Jul 29 2016 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | CEO and CFO | Buy | P | 1.00 | 137,500 | 137,500 | 137,500 | 0 to 137.5 K |
Jul 15 2015 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Acting CFO | Option Exercise | A | 0.21 | 250,000 | 52,500 | 430,000 | |
Jul 19 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | J | 0.00 | 3,837 | 0 | 4,348,937 | 4.3 M to 4.3 M (+0.09 %) |
Jul 15 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.56 | 50,000 | 28,000 | 794,726 | |
Jun 10 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.48 | 23,100 | 11,088 | 4,345,100 | 4.3 M to 4.3 M (+0.53 %) |
May 21 2010 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.62 | 16,000 | 9,920 | 4,322,000 | 4.3 M to 4.3 M (+0.37 %) |
Aug 18 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.45 | 24,972 | 11,237 | 3,701,200 | 3.7 M to 3.7 M (+0.68 %) |
Jul 13 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.49 | 20,000 | 9,800 | 3,377,767 | 3.4 M to 3.4 M (+0.60 %) |
May 29 2009 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Buy | P | 0.50 | 10,000 | 5,000 | 3,297,767 | 3.3 M to 3.3 M (+0.30 %) |
Dec 17 2008 | NUOT | Nuo Therapeutics, ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 |
Page: 1